. Author manuscript; available in PMC: 2012 Sep 4.

Published in final edited form as: Oncol Rep. 2011 Jan 14;25(3):855–862. doi: 10.3892/or.2011.1147

Table II.

Genes down-regulated in response to bevacizumab treatment.

Gene	Abbreviation	Accession no.	Fold-change		Proposed reason for regulation
Gene	Abbreviation	Accession no.	Affymetrix	qRT-PCR	Proposed reason for regulation
Rho GTPase activating protein 6 transcript variant 1	ARHGAP6	NM_013427.2	−1.15	−0.49	Sensitivity
Matrix metallopeptidase 15	MMP15	NM_002428.2	−6.70	−0.36	Sensitivity
Collagen, type IX, α 3	COL9A2	NM_001853.3	−1.27	−0.25	Sensitivity
PR domain containing 16	PRDM16	NM_022114.2	−2.47	−0.40	Resistance
Programmed cell death 4	PDCD4	NM_145341.2	−1.56	−0.23	Resistance